Furthermore, the decrease in c-Myc acetylation in TACC3-depleted BC cells was rescued by PCAF overexpression, whereas PCAF silencing reversed the hyperacetylation induced by TACC3 overexpression (Fig. 6C, D). The gene discussed is KAT2B; the disease is breast cancer.